-
Transgemonic Up Another 33% Following Yesterday's 295% Run
Friday, January 13, 2017 - 8:38am | 300Read More...Transgenomic Inc (NASDAQ: TBIO), a nano-cap biotechnology engaged in advancing personalized medicine for the detection and treatment of cancer, skyrocketed higher by 295 percent Thursday. Transgenomic's stock gained $0.84 per share Thursday and closed at $1.12 after hitting an intra-day high of $1....
